CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Activity

150 hedge funds and large institutions have $2.28B invested in Celldex Therapeutics in 2013 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 46 increasing their positions, 50 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
150
Holders Change
+21
Holders Change %
+16.28%
% of All Funds
4.87%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
41
Increased
46
Reduced
50
Closed
18
Calls
$73.3M
Puts
$32.4M
Net Calls
+$40.9M
Net Calls Change
+$42M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$423M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$135M
3
SAM
3
Sectoral Asset Management
Quebec, Canada
$33.5M
4
TCM
4
TimesSquare Capital Management
New York
$65.9M
5
Viking Global Investors
5
Viking Global Investors
Connecticut
$23.8M

Top Sellers

1
SCA
1
SAC Capital Advisors
Connecticut
$52.8M
2
HM
2
HealthCor Management
New York
$932K
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$0
4
PCA
4
Private Capital Advisors
Connecticut
$6.14M
5
BA
5
BlackRock Advisors
Delaware
$42.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
EA
26
Emerald Advisers
Pennsylvania
$16.1M +$1.31M +2,464 +9%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$14.8M +$2.81M +5,285 +23%
Ameriprise
28
Ameriprise
Minnesota
$14M +$11.2M +21,108 +405%
TCIM
29
TIAA CREF Investment Management
New York
$13.3M -$399K -751 -3%
FAM
30
Fred Alger Management
New York
$12.6M +$12.6M +23,677 New
Citadel Advisors
31
Citadel Advisors
Florida
$12.3M +$9.38M +17,648 +325%
DCM
32
Driehaus Capital Management
Illinois
$11.5M +$11.5M +21,573 New
BG
33
BlackRock Group
United Kingdom
$10.7M -$2.29M -4,305 -18%
JPMorgan Chase & Co
34
JPMorgan Chase & Co
New York
$10.4M -$1.44M -2,707 -12%
Susquehanna International Group
35
Susquehanna International Group
Pennsylvania
$10.4M +$2.75M +5,174 +36%
SCM
36
Sigma Capital Management
Connecticut
$9.92M -$3.72M -7,000 -27%
RA
37
Royce & Associates
New York
$9.67M -$4.5M -8,467 -32%
AAP
38
Ardsley Advisory Partners
Connecticut
$9.39M -$5.14M -9,666 -35%
CCM
39
Cupps Capital Management
Illinois
$9.02M +$9.02M +16,977 New
O
40
OppenheimerFunds
New York
$8.82M +$8.82M +16,594 New
BIM
41
BlackRock Investment Management
Delaware
$8.19M +$434K +816 +6%
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$8.05M +$1.13M +2,124 +16%
EMFAT
43
Emerald Mutual Fund Advisers Trust
Pennsylvania
$7.92M +$199K +375 +3%
Millennium Management
44
Millennium Management
New York
$7.66M -$672K -1,264 -8%
Charles Schwab
45
Charles Schwab
California
$7.52M +$307K +541 +4%
Goldman Sachs
46
Goldman Sachs
New York
$6.81M +$2.29M +4,317 +51%
PCA
47
Private Capital Advisors
Connecticut
$6.14M -$23M -43,291 -79%
RFC
48
Russell Frank Company
Washington
$5.74M -$2.38M -4,486 -29%
NIP
49
Nicholas Investment Partners
California
$5.74M +$5.74M +10,793 New
GC
50
Guggenheim Capital
Illinois
$5.67M -$1.16M -2,177 -17%
1
2
3 4 5